Steatohepatitis

22 registered clinical trials studyying Steatohepatitis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Diagnosis and Quantification of Hepatic Steatosis Using Near-infrared Spectroscopy NCT07254533	Assistance Publique Hopitaux De Marseille	N/A
Recruiting	Expanded Studies on the SCAPIS Stockholm Reexamination Cohort NCT07476703	Danderyd Hospital	—
Terminated	A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NA NCT05864391	AstraZeneca	Phase 1
Unknown	Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). NCT05946330	Universidade Federal do Paraná	N/A
Recruiting	Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal NCT05640947	University Hospital, Ghent	N/A
Terminated	A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic S NCT07052682	Takeda	Phase 1
Completed	Integrated Approaches for Identifying Molecular Targets in Liver Disease NCT03915002	University of Pittsburgh	—
Unknown	PET-MR Study of Fatty Liver NCT04063826	Imperial College London	N/A
Active Not Recruiting	Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity NCT02378259	Göteborg University	N/A
Completed	Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients NCT02009592	Bezmialem Vakif University	N/A
Completed	A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection NCT01645852	Dartmouth-Hitchcock Medical Center	N/A
Terminated	A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury NCT01523639	Austrian Breast & Colorectal Cancer Study Group	Phase 2
Completed	Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease NCT01556113	Yale University	N/A
Completed	Prognostic Indicators as Provided by the EPIC ClearView NCT01476995	Epic Research & Diagnostics, Inc.	—
Completed	Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (N NCT01154985	Mochida Pharmaceutical Company, Ltd.	Phase 2
Unknown	Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic Hepatopathy NCT01246388	Tischendorf, Jens, M.D.	—
Completed	Fatty Liver and Ectopic Fat in Overweight and Obese Patients NCT00886301	Centre Hospitalier Universitaire de Nice	N/A
Completed	Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease NCT01147523	Aristotle University Of Thessaloniki	Phase 2
Unknown	Identification of Protective and Worsening Steatohepatitis (NASH) Factors NCT00914446	Centre Hospitalier Universitaire de Nice	N/A
Completed	Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV NCT00575757	Virginia Commonwealth University	—
Completed	Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass NCT00512512	Johns Hopkins University	—
Completed	Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy NCT00326482	National Institute of Allergy and Infectious Diseases (NIAID)	—